"Misiunea noastra principala este de a ajuta pacientii sa atinga potentialul lor maxim de sanatate intr-un mod cat mai eficient posibil. Cea mai de pret comoara este sanatatea. Pentru a va bucura pe deplin de ea acordati-va sansa de a beneficia de servicii medicale de calitate, pe care cabinetul nostru vi le ofera cu profesionalism."

During the past decade, Pan Medical Sibiu conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pan Medical Sibiu" #1 collaborator was "MDX Research" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pan Medical Sibiu" are "Bacterial Vaginosis" (1 trials), "Vaginal Atrophy" (1 trials) and "Vaginitis" (1 trials). Many other conditions were trialed in "Pan Medical Sibiu" in a lesser frequency.

Most popular intervention types in "Pan Medical Sibiu" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cerviron®" (1 trials) and "Halova" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pan Medical Sibiu" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Pan Medical Sibiu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pan Medical Sibiu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pan Medical Sibiu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".